CTI BioPharma CEO James Bianco's 2007 pay rises 3% to $2.2M
CTI BioPharma reports 2007 executive compensation
By ExecPay News
Published: May 23, 2008
CTI BioPharma reported fiscal year 2007 executive compensation information on May 23, 2008.
In 2007, six executives at CTI BioPharma received on average a compensation package of $927K, a 1% decrease compared to previous year.
Average pay of disclosed executives at CTI BioPharma
James A. Bianco, Chief Executive Officer, received $2.2M in total, which increased by 3% compared to 2006. 30% of Bianco's compensation, or $650K, was in salary. Bianco also received $488K in bonus, $374K in option awards, $532K in stock awards, as well as $155K in other compensation.
Jack W. Singer, Chief Medical Officer, received a compensation package of $811K, which decreased by 6% compared to previous year. 42% of the compensation package, or $340K, was in salary.
Louis A. Bianco, Executive Vice President, Finance and Administration, earned $758K in 2007, a 7% decrease compared to previous year.
Daniel G. Eramian, Executive Vice President, Corporate Communications, received $698K in 2007.
Dan Eramian, Executive Vice President, Corporate Communications, earned $565K in 2007, a 3% increase compared to previous year.
Scott Stromatt, Executive Vice President, Clinical Development and Regulatory Affairs, received $533K in 2007, which decreases by 24% compared to 2006.
Related executives
James Bianco
CTI BioPharma
Chief Executive Officer
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
Daniel Eramian
CTI BioPharma
Former Executive Vice President Corporate Communications
Jack Singer
CTI BioPharma
Chief Scientific Officer
Dan Eramian
CTI BioPharma
Executive Vice President, Corporate Communications
Scott Stromatt
CTI BioPharma
Executive Vice President, Clinical Development and Regulatory Affairs
You may also like
Source: SEC filing on May 23, 2008.